TuBerculosis Vaccine Initiative
In research, TuBerculosis Vaccine Initiative stands highest in Medicine (#11,379 of 17,978 worldwide) and Health Sciences (#14,169 of 20,462 worldwide), over all time.
- World rank, all time
- #21,925 of 42,892
- Rank in Netherlands
- #264 of 464
- Research works
- 287 ▼ 6% vs 2013–17
- Citations
- 8.7k 30.5 per fractional work
- Top-10% rate
- 21.6% record average 16.5%
- Open access
- 61% world 28%
What is TuBerculosis Vaccine Initiative known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #11,379 of 17,978 | 25.3% | 162 | |
| Health SciencesDomain | #14,169 of 20,462 | 25.3% | 178 |
Each strip is that field’s whole ranked pool, with the notch where TuBerculosis Vaccine Initiative sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 7.4×. Every wedge is a field page.
- Veterinary 7.4×
- Immunology and Microbiology 4.5×
- Medicine 3.0×
- Psychology 1.9×
- Health Professions 1.9×
- Neuroscience 1.7×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Nursing 1.2×
- Social Sciences 0.9×
- Economics, Econometrics and Finance 0.7×
- Mathematics 0.6×
- Business, Management and Accounting 0.5×
- Agricultural and Biological Sciences 0.4×
- Biochemistry, Genetics and Molecular Biology 0.3×
- Environmental Science 0.3×
- Arts and Humanities 0.2×
- Computer Science 0.2×
- Chemistry 0.1×
- Decision Sciences 0.1×
- Materials Science 0.0×
- Engineering 0.0×
Who are the top researchers at TuBerculosis Vaccine Initiative?
Ranked on the composite score, Edine Tiemersma lead among researchers whose main affiliation is TuBerculosis Vaccine Initiative.
- 1 Edine Tiemersma Netherlands · #342,222 worldwide 76 citations · 19 works
Which keywords describe research at TuBerculosis Vaccine Initiative?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Diagnosis, Vaccine, Immune Response, Drug Resistance, Mycobacterium tuberculosis and Tuberculosis.
- Vaccine Hesitancy
- COVID-19 Vaccine
- Psychological Distress
- Environmental Quality
- ACE2 Receptor
- Innate Memory
- Chronic Disease Management
- Social Inequality
- Mycobacterium avium
- Cystic Fibrosis
- Diagnostic Challenges
- Pneumococcal Conjugate Vaccine
- Antimicrobial Resistance
- COVID-19
- Public Health
- Pandemic
- Tuberculosis
- Drug Resistance
- Vaccine
- Treatment
- Epidemiology
- Diagnosis
- Immune Response
- Mycobacterium tuberculosis
- Antiretroviral Therapy
- Clinical Practice Guidelines
- Antibiotic Resistance
- Infectious Diseases
- Community-Acquired Pneumonia
- Abdominal Tuberculosis
- SARS-CoV-2
- Health Behavior
- Nontuberculous Mycobacteria
- Viral Load
- HIV Infection
- Trained Immunity
- Community Engagement
- Mortality Rates
- Urban Planning
- HIV Transmission
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology17▲ 8.7×29 topics
- Treatment12▲ 20×9 topics
- Diagnosis12▲ 26×7 topics
- Vaccine11▲ 54×7 topics
- Immune Response10▲ 36×6 topics
- Drug Resistance10▲ 71×4 topics
- Mycobacterium tuberculosis9▲ 334×1 topic
- Tuberculosis9▲ 354×1 topic
- Antiretroviral Therapy3▲ 42×6 topics
- Pandemic3▲ 5.3×8 topics
- Clinical Practice Guidelines2▲ 9.4×3 topics
- Public Health2▲ 3.0×8 topics
- Antibiotic Resistance2▲ 11×4 topics
- COVID-192▲ 3.1×10 topics
- Infectious Diseases2▲ 12×4 topics
- Antimicrobial Resistance2▲ 17×2 topics
- Community-Acquired Pneumonia2▲ 99×1 topic
- Pneumococcal Conjugate Vaccine2▲ 99×1 topic
- Abdominal Tuberculosis2▲ 171×1 topic
- Diagnostic Challenges2▲ 171×1 topic
- SARS-CoV-22▲ 10×4 topics
- Cystic Fibrosis2▲ 44×2 topics
- Health Behavior2▲ 29×2 topics
- Mycobacterium avium2▲ 89×1 topic
- Nontuberculous Mycobacteria2▲ 89×1 topic
- Social Inequality2▲ 12×3 topics
- Viral Load2▲ 37×2 topics
- Chronic Disease Management1▲ 15×3 topics
- HIV Infection1▲ 25×3 topics
- Innate Memory1▲ 122×1 topic
- Trained Immunity1▲ 122×1 topic
- ACE2 Receptor1▲ 10×2 topics
- Community Engagement1▲ 7.6×2 topics
- Environmental Quality1▲ 195×1 topic
- Mortality Rates1▲ 26×2 topics
- Psychological Distress1▲ 10.0×3 topics
- Urban Planning1▲ 29×1 topic
- COVID-19 Vaccine1▲ 32×1 topic
- HIV Transmission1▲ 31×1 topic
- Vaccine Hesitancy1▲ 35×1 topic
Which research topics does TuBerculosis Vaccine Initiative publish most on?
By volume in 2022–2025: Tuberculosis Research and Epidemiology, Pneumonia and Respiratory Infections, Diagnosis and treatment of tuberculosis and Mycobacterium research and diagnosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Tuberculosis Research and Epidemiology Infectious Diseases 9 works
- 2 Pneumonia and Respiratory Infections Epidemiology 2 works
- 3 Diagnosis and treatment of tuberculosis Surgery 2 works
- 4 Mycobacterium research and diagnosis Epidemiology 2 works
- 5 Immune responses and vaccinations Immunology 1 works
- 6 Healthcare Facilities Design and Sustainability Urban Studies 1 works
- 7 Vaccine Coverage and Hesitancy Health 1 works
- 8 HIV/AIDS Research and Interventions Infectious Diseases 1 works
- 9 Mobile Health and mHealth Applications General Health Professions 1 works
- 10 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has TuBerculosis Vaccine Initiative's research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lelystad
- Schothorst Feed Research
- International Commission for the Hydrology of the Rhine Basin
- HKV (Netherlands)
- Pepscan (Netherlands)
- Goodlife (Netherlands)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.